Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,144 | -9,277 | -8,247 | -25,091 | -25,828 |
| Depreciation Amortization | 1,191 | 649 | 195 | 759 | 726 |
| Accounts receivable | -25 | 1,646 | 3,038 | 9,770 | 16,774 |
| Accounts payable and accrued liabilities | -3,327 | -1,012 | 2,134 | -366 | 491 |
| Other Working Capital | 2,350 | -3,745 | -2,095 | 9,517 | 18,350 |
| Other Operating Activity | 13,635 | 7,028 | -38 | -332 | -10,016 |
| Operating Cash Flow | $16,968 | $-4,711 | $-5,013 | $-5,743 | $497 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,388 | 11,602 | 451 | 10,444 | 17,428 |
| PPE Investments | 16 | N/A | N/A | 259 | 149 |
| Purchase Sale Intangibles | -360 | -360 | -138 | -15,000 | -15,000 |
| Other Investing Activity | -360 | -360 | -138 | -15,000 | -15,000 |
| Investing Cash Flow | $15,044 | $11,242 | $313 | $-4,297 | $2,577 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 19,950 |
| Common Stock Issued | 499 | 341 | 89 | 1,049 | 563 |
| Other Financing Activity | -13,605 | -3,605 | -2,601 | 17,318 | -2,632 |
| Financing Cash Flow | $-13,106 | $-3,264 | $-2,512 | $18,367 | $17,881 |
| Beginning Cash Position | 32,786 | 32,786 | 32,786 | 24,459 | 24,459 |
| End Cash Position | 51,692 | 36,053 | 25,574 | 32,786 | 45,414 |
| Net Cash Flow | $18,906 | $3,267 | $-7,212 | $8,327 | $20,955 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,968 | -4,711 | -5,013 | -5,743 | 497 |
| Capital Expenditure | -10 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 16,958 | -4,711 | -5,013 | -5,743 | 497 |